Stockreport

IPAX-1 Study of TLX101 Investigational Glioblastoma Therapy Published in Neuro-Oncology Advances [Yahoo! Finance]

ASX LTD UNSP/ADR  (ASXFY) 
NASDAQ:AMEX Investor Relations: asx.com.au/about/investor-relations.htm
PDF Company's IPAX-1 Phase I study has been published in Neuro-Oncology Advances, confirming the safety and tolerability profile, and early efficacy of TLX101 therapy, in co [Read more]